Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinma Ren

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Hospital Pediatrics|June 3, 2015
Epidemiology of Bacteremia in Previously Healthy Febrile Infants: A Follow-up StudyMatthew Mischler, Michael S Ryan, JoAnna K Leyenaar, et al.
Journal of Occupational and Environmental Medicine|March 15, 2024
COVID-19-Related Work Absenteeism and Associated Lost Productivity Cost in Germany: A Population-Based StudyJingyan Yang, Kiran K Rai, Monica Seif, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 22, 2013
Systemic therapy for colorectal cancer: patterns of chemotherapy and biologic therapy use in nationally representative US claims databaseBrian S Seal, Sean D Sullivan, Scott D Ramsey, et al.
Journal of Managed Care Pharmacy : JMCP|June 29, 2013
Medical costs associated with use of systemic therapy in adults with colorectal cancerBrian S Seal, Sean D Sullivan, Scott Ramsey, et al.
JAMA Pediatrics|July 23, 2014
Blood culture time to positivity in febrile infants with bacteremiaEric A Biondi, Matthew Mischler, Karen E Jerardi, et al.
Frontiers in Medicine|November 29, 2023
Regulatory agilities impacting review timelines for Pfizer/BioNTech's BNT162b2 mRNA COVID-19 vaccine: a retrospective studyPrisha Patel, Judith C Macdonald, Jayanthi Boobalan, et al.
Vaccines|February 24, 2024
Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide StudyManuela Di Fusco, Xiaowu Sun, Kristen E Allen, et al.
Future Oncology (London, England)|February 28, 2024
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myelomaLuciano J Costa, Thomas W LeBlanc, Hans Tesch, et al.
Journal of Medical Economics|March 31, 2025
All-cause healthcare resource utilization and costs among community-managed adults with long-COVID in France, 2020-2023Jingyan Yang, Cheikh Tamberou, Elise Arnee, et al.
BMC Public Health|April 17, 2015
Impact evaluation of a community-based intervention to reduce risky sexual behaviour among female sex workers in Shanghai, ChinaJuan Liu, Liviana Calzavara, Joshua B Mendelsohn, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Hospital Pediatrics|June 3, 2015
Epidemiology of Bacteremia in Previously Healthy Febrile Infants: A Follow-up StudyMatthew Mischler, Michael S Ryan, JoAnna K Leyenaar, et al.
Journal of Occupational and Environmental Medicine|March 15, 2024
COVID-19-Related Work Absenteeism and Associated Lost Productivity Cost in Germany: A Population-Based StudyJingyan Yang, Kiran K Rai, Monica Seif, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 22, 2013
Systemic therapy for colorectal cancer: patterns of chemotherapy and biologic therapy use in nationally representative US claims databaseBrian S Seal, Sean D Sullivan, Scott D Ramsey, et al.
Journal of Managed Care Pharmacy : JMCP|June 29, 2013
Medical costs associated with use of systemic therapy in adults with colorectal cancerBrian S Seal, Sean D Sullivan, Scott Ramsey, et al.
JAMA Pediatrics|July 23, 2014
Blood culture time to positivity in febrile infants with bacteremiaEric A Biondi, Matthew Mischler, Karen E Jerardi, et al.
Frontiers in Medicine|November 29, 2023
Regulatory agilities impacting review timelines for Pfizer/BioNTech's BNT162b2 mRNA COVID-19 vaccine: a retrospective studyPrisha Patel, Judith C Macdonald, Jayanthi Boobalan, et al.
Vaccines|February 24, 2024
Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide StudyManuela Di Fusco, Xiaowu Sun, Kristen E Allen, et al.
Future Oncology (London, England)|February 28, 2024
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myelomaLuciano J Costa, Thomas W LeBlanc, Hans Tesch, et al.
Journal of Medical Economics|March 31, 2025
All-cause healthcare resource utilization and costs among community-managed adults with long-COVID in France, 2020-2023Jingyan Yang, Cheikh Tamberou, Elise Arnee, et al.
BMC Public Health|April 17, 2015
Impact evaluation of a community-based intervention to reduce risky sexual behaviour among female sex workers in Shanghai, ChinaJuan Liu, Liviana Calzavara, Joshua B Mendelsohn, et al.
Pageof 6